{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:26:32Z","timestamp":1793183192000,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.biopha.2022.113167","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T23:23:15Z","timestamp":1653348195000},"page":"113167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Monitoring of lamotrigine concentrations in mothers, colostrum, and breastfed newborns during the early postpartum period"],"prefix":"10.1016","volume":"151","author":[{"given":"Ivana","family":"Kacirova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Brozmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2022.113167_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113167_bib2","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00415-020-09764-w","article-title":"Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure","volume":"267","author":"Huber-Mollema","year":"2020","journal-title":"J. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2022.113167_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/brain\/awq352","article-title":"Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age","volume":"134","author":"Meador","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.biopha.2022.113167_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2009.02.011","article-title":"Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period","volume":"85","author":"Fotopoulou","year":"2009","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.113167_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ana.25321","article-title":"Lamotrigine clearance increases by 5 weeks gestational age: relationship to estradiol concentrations and gestational age","volume":"84","author":"Karanam","year":"2018","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113167_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.59.2.251","article-title":"Lamotrigine clearance during pregnancy","volume":"59","author":"Tran","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.biopha.2022.113167_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000133213.10244.FD","article-title":"Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study","volume":"63","author":"de Haan","year":"2004","journal-title":"Neurology"},{"issue":"22 Pt 2","key":"10.1016\/j.biopha.2022.113167_bib8","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2022.113167_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eplepsyres.2018.01.011","article-title":"UGT polymorphisms and lamotrigine clearance during pregnancy","volume":"140","author":"Petrenaite","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biopha.2022.113167_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105610","article-title":"Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: recommendations for pregnant women with epilepsy","volume":"169","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2022.113167_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eplepsyres.2010.07.007","article-title":"Serum levels of lamotrigine during delivery in mothers and their infants","volume":"91","author":"Kacirova","year":"2010","journal-title":"Epilepsy Res."},{"issue":"9","key":"10.1016\/j.biopha.2022.113167_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1528-1157.1997.tb01489.x","article-title":"Lamotrigine in pregnancy and lactation: a case report","volume":"38","author":"Tomson","year":"1997","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.biopha.2022.113167_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1528-1157.2000.tb00232.x","article-title":"Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation","volume":"41","author":"Ohman","year":"2000","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.biopha.2022.113167_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00228-002-0544-4","article-title":"Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo","volume":"58","author":"Myllynen","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113167_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/FTD.0000000000000604","article-title":"A short communication: Lamotrigine levels in milk, mothers, and breastfed infants during the first postnatal month","volume":"41","author":"Kacirova","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.biopha.2022.113167_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaneurol.2019.4443","article-title":"Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy","volume":"77","author":"Birnbaum","year":"2020","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113167_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.2007-3812","article-title":"Lamotrigine in breast milk and nursing infants: determination of exposure","volume":"122","author":"Newport","year":"2008","journal-title":"Pediatrics"},{"issue":"suppl.2","key":"10.1016\/j.biopha.2022.113167_bib18","first-page":"72","article-title":"Pharmacokinetics of lamotrigine excretion into human breast milk","volume":"66","author":"Pennell","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.biopha.2022.113167_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40262-018-0713-y","article-title":"Comprehensive measurements of intrauterine and postnatal exposure to lamotrigine","volume":"58","author":"Paulzen","year":"2019","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.biopha.2022.113167_bib20","first-page":"470","article-title":"Transfer of lamotrigine into breast milk","volume":"40","author":"Page-Sharp","year":"2006","journal-title":"Lett. Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113167_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.reprotox.2016.03.032","article-title":"Levetiracetam and lamotrigine excretion in breast milk","volume":"60","author":"Kohn","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.biopha.2022.113167_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2003.11.018","article-title":"Concerns regarding lamotrigine and breast-feeding","volume":"5","author":"Liporace","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2022.113167_bib23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1176\/appi.ajp.2013.13010006","article-title":"Lamotrigine dosing for pregnant patients with bipolar disorder","volume":"170","author":"Clark","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2022.113167_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s002280050234","article-title":"Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child","volume":"51","author":"Rambeck","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113167_bib25","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1345\/aph.1M254","article-title":"Severe apnea in an infant exposed to lamotrigine in breast milk","volume":"43","author":"Nordmo","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113167_bib26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1528-1157.1997.tb01489.x","article-title":"Lamotrigine in pregnancy and lactation: a case report","volume":"38","author":"Tomson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2022.113167_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jpc.13805","article-title":"Normocytic normochromic anaemia and asymptomatic neutropenia in a 40- day-old infant breastfed by an epileptic mother treated with lamotrigine: infant\u2019s adverse drug reaction","volume":"54","author":"Bedussi","year":"2018","journal-title":"J. Paediatr. Child Health"},{"issue":"5","key":"10.1016\/j.biopha.2022.113167_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 Update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.biopha.2022.113167_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharm. Res. Perspect."},{"key":"10.1016\/j.biopha.2022.113167_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2014.02.011","article-title":"Carbamazepine clearance and seizure stability during pregnancy","volume":"33","author":"Johnson","year":"2014","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.biopha.2022.113167_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jssc.200700253","article-title":"Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC","volume":"31","author":"Budakova","year":"2008","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.biopha.2022.113167_bib32","unstructured":"US Food and drug administration Guidance for industry. Bioanalytical method validation US department of health and human services, Food and drug administration, 2001."},{"issue":"3","key":"10.1016\/j.biopha.2022.113167_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/pharmaceutics13030398","article-title":"Umbilical cord, maternal milk, and breastfed infant levetiracetam concentrations monitoring at delivery and during early postpartum period","volume":"13","author":"Kacirova","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.113167_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111446","article-title":"Monitoring topiramate concentrations at delivery and during lactation","volume":"138","author":"Kacirova","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113167_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00003088-199325060-00003","article-title":"Lamotrigine clinical pharmacokinetics","volume":"5","author":"Rambeck","year":"1993","journal-title":"Clin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2022.113167_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cpt.1109","article-title":"Age- and genotype-dependent ariability in the protein abundance and activity of six major uridine diphosphate-glucuronosyltransferases in human liver","volume":"105","author":"Bhatt","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2022.113167_bib37","first-page":"222","article-title":"Drug interaction between lamotrigine and valproic acid used at delivery and during lactation \u2013 a case report. [In Czech language]","volume":"24","author":"Kacirova","year":"2010","journal-title":"Klin. Farmakol. Farm."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222200556X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222200556X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:06:37Z","timestamp":1787598397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222200556X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"alternative-id":["S075333222200556X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113167","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring of lamotrigine concentrations in mothers, colostrum, and breastfed newborns during the early postpartum period","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113167"}}